Catheterization and Cardiovascular Interventions
Volume 90, Issue 7 pp. 1084-1085
Coronary Artery Disease

Deferred lesion failure in diabetes: A truly bad actor

Arnold H. Seto MD, MPA, FSCAI, FACC, 

Corresponding Author

Arnold H. Seto MD, MPA, FSCAI, FACC

Department of Medicine, Long Beach Veterans Affairs Medical Center

Department of Medicine, University of California, Irvine Medical Center

Correspondence Arnold H. Seto MD, MPA, Long Beach Veteran's Administration Medical Center, 5901 East 7th Street, 111C, Long Beach, CA 90822. Email: [email protected]Search for more papers by this author
Morton J. Kern MD MSCAI, FACC, FAHA, 

Morton J. Kern MD MSCAI, FACC, FAHA

Department of Medicine, Long Beach Veterans Affairs Medical Center

Department of Medicine, University of California, Irvine Medical Center

Search for more papers by this author
First published: 11 December 2017
https://doi.org/10.1002/ccd.27419
Citations: 3

Key Points

  • DM patients with stenoses whose FFR > 0.80 have a relatively high 14% rate of deferred lesion failure (i.e., revascularization or MI).
  • IDDM and prior revascularization were independent predictors of deferred lesion failure
  • FFR predicts outcomes, but is a less effective predictor in diabetics due to diffuse atherosclerosis microvascular disease.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.